[DOI] [PubMed] [Google Scholar] 101.Currie B.J., Jacups S.P., Cheng A.C., Fisher D.A., Anstey N.M., Huffam S.E., Krause V.L
Then, on October 2, 2024, the FDA removed tirzepatide from the shortage list, stating that the supply had stabilized
The class, which also includes Trulicity, Saxenda, Rybelsus and others, has skyrocketed in popularity in recent years as the medications became linked with increased weight loss and beneficial metabolic effects
Our team understands the importance of integrating advanced medical treatments with compassionate support
This resulted in a significantly greater improvement in the TyG index at week 12 in the high GLP-1 group compared to the low GLP-1 group [between-group difference -0.19 (95% CI -0.39, -0.01)] ( Table 4 )
Confirmatory factor analysis was conducted to confirm unidimensional scaling